FDA Approves First Immune Globulin for Subcutaneous Use: "FDA today announced the approval of the first immune globulin product for subcutaneous injection for the prevention of serious infections in patients with Primary Immune Deficiency Diseases (PIDD)"
Tuesday, January 10, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment